Bavarian Nordic A/S 2022 SR
The report highlights Bavarian Nordic's role in the global response to the 2022 mpox outbreak, delivering over 4 million vaccine doses. The company initiated Phase 3 trials for RSV and COVID-19 booster vaccines while integrating ESG targets into executive remuneration. Environmental efforts focused on production efficiency, resulting in a 4% decrease in production emissions despite overall growth. Social achievements included maintaining gender diversity in management and significantly reducing the workplace accident rate (LTIFR) to 1.3.
Company: Bavarian Nordic A/S
Sector: Manufacturing
Country: Denmark
Year: 2022
Type: SR
Pages: 45
Back to company
Bavarian Nordic A/S
Sustainability Report
The report highlights Bavarian Nordic's role in the global response to the 2022 mpox outbreak, delivering over 4 million vaccine doses. The company initiated Phase 3 trials for RSV and COVID-19 booster vaccines while integrating ESG targets into executive remuneration. Environmental efforts focused on production efficiency, resulting in a 4% decrease in production emissions despite overall growth. Social achievements included maintaining gender diversity in management and significantly reducing the workplace accident rate (LTIFR) to 1.3.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2022
Reporting Period
Jan 1, 2022 - Dec 31, 2022
Fiscal Year
2022
Published
Mar 2, 2023
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
Sustainable Development Goals
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Water Consumption
Total Waste
Women on Board
Women in Management
Employees